US removes Defense Production Act ratings for some vaccines

The U.S. recently removed priority ratings from vaccine orders from Novavax, AstraZeneca and Sanofi. (Photo: Novavax)

This is an excerpt from Medically Necessary, a health care supply chain newsletterSubscribe here.

The decision: Last week, the U.S. announced it was removing the priority ratings issued under the Defense Production Act for vaccines made by Sanofi, AstraZeneca and Novavax. Orders for other vaccines remain prioritized.

The Defense Production Act, or DPA, allows the president to place priority ratings on government orders, which compels companies to accept and prioritize those orders.  Companies...

https://www.freightwaves.com/news/us-removes-defense-production-act-ratings-for-some-vaccines

Hear from WHO, Novavax, UNICEF, Gavi, UPS Healthcare, Aramex & more around vaccine logistics

Hear from WHO, Novavax, UNICEF, Gavi, UPS Healthcare, Aramex & more around vaccine logistics

VISIT WEBSITE REGISTER FOR FREE

The HOPE Consortium invites you to join for an exclusive 3D virtual event facilitating open dialogue around the logistical challenges of global vaccine distribution.

Speakes Include:
H.E. Abdullah Bin Mohammed Al Hamed
ChairmanDepartment of Health –Abu Dhabi

H.E. Falah Mohammed Al Ahbabi Chairman Abu Dhabi Ports

Nadhim Zahawi MP
Parliamentary Under Secretary of State and...

https://allaboutshipping.co.uk/2021/03/21/hear-from-who-novavax-unicef-gavi-ups-healthcare-aramex-more-around-vaccine-logistics/

Medically Necessary: Delaying second doses would reshape the vaccine supply chain

vaccine-vial

This is an excerpt from the February 25, 2021 edition of Medically Necessary, a health care supply chain newsletterSubscribe here.

Good afternoon. Medically Necessary is a newsletter by Matt Blois about the health care supply chain — how we get drugs, devices and medical supplies to health care providers and patients.

Delaying second doses would reshape the vaccine supply chain

The debate: Some scientists argue the U.S. should delay second doses of COVID-19 vaccines and instead give them to...

https://s29755.pcdn.co/news/medically-necessary-delaying-second-doses-would-reshape-the-vaccine-supply-chain

Novavax On The Verge of Making History?

The small vaccinemaker that faced an existential threat is slated to receive up to $2 billion from the U.S. government and a nonprofit organization to develop and manufacture a coronavirus vaccine, says an article published in ScienceMag.

A turnover like no one imagined

Eighteen months ago, a small vaccine maker here called Novavax faced an existential threat: delisting by the NASDAQ stock index. On the heels of a second failed vaccine trial in less than 3 years, the firm’s shares had plunged to...

https://mfame.guru/novavax-on-the-verge-of-making-history/

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.